GlassScriptPhysician profile
Pamela Lavrich
NPI 1255492310
$793.26
in general payments reported to CMS, 2019-2025
15 companies · $230 in 2025
The $230 reported for 2025 was more than what 83% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.83 · 2021: $14.07 · 2022: $56.70 · 2023: $89.88 · 2024: $362 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666 · Education: $15.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.07 |
| Education | $15.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $165.60 | 2024-2025 | Korlym |
| Janssen Biotech, INC. | $91.25 | 2023-2025 | Stelara, Tremfya |
| Qol Medical, LLC | $90.12 | 2024-2025 | Sucraid, Sucraid |
| Cumberland Pharmaceuticals, INC. | $82.30 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $68.63 | 2024-2025 | Dupixent |
| Lilly USA, LLC | $53.88 | 2024 | Omvoh |
| Takeda Pharmaceuticals U.S.A., INC. | $50.47 | 2023-2025 | Entyvio |
| Medline Industries LP | $43.80 | 2023 | |
| Aurinia Pharma U.S., INC. | $43.63 | 2024 | Lupkynis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.00 | 2024-2025 | Trulance |
| Celltrion USA INC. | $15.59 | 2024 | Zymfentra |
| Xeris Pharmaceuticals, INC. | $14.89 | 2023 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $14.86 | 2020 | |
| Phathom Pharmaceuticals, INC. | $14.80 | 2024 | Voquezna |
| Mallinckrodt Hospital Products INC. | $14.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Lavrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.